Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.75%
#4 Black Phoenix Black Phoenix +335.99%
#5 aPriori aPriori +116.11%
#6 Bedrock Bedrock +74.68%
#7 Cysic Cysic +47.27%
#8 Prom Prom +42.47%
#9 Playnance Playnance +34.82%
#10 COTI COTI +30.34%
Coin of the day
Wrapped One Wrapped One
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Rosetta Genomics Ltd. Rosetta Genomics Ltd.

Rosetta Genomics Ltd.

ROSGQ
Rang în acțiuni #42629
Rosetta Genomics Ltd. is a global entity specializing in genomic diagnostics.... Rosetta Genomics Ltd. is a global entity specializing in genomic diagnostics. The company leverages its proprietary microRNA technologies to offer a range of diagnostic assays, including RosettaGX Cancer Origin, which helps pinpoint the primary source of metastatic cancer; mi-KIDNEY, designed for classifying kidney tumors from pathological specimens; RosettaGX Reveal, used to interpret indeterminate thyroid fine-needle aspirate results; and various mi-LUNG diagnostic tests. In addition to its microRNA-based portfolio, Rosetta Genomics provides UroVysion, a urine-based Fluorescence In Situ Hybridization (FISH) assay. This assay serves as an adjunct to, rather than a substitute for, conventional diagnostic methods, aiding in the initial detection of bladder carcinoma in patients with hematuria and in the ongoing surveillance for tumor recurrence in those previously diagnosed with bladder cancer. The company also offers ERG/PTEN, which are FISH-based tests providing prognostic information for prostate cancer. Furthermore, Rosetta Genomics supplies ALK/ROS1, a set of FISH-based predictive tests specifically intended for individuals with late-stage lung cancer, along with PCR gene mutation analysis for patients with bladder, lung, colon, and melanoma cancers. Its diagnostic solutions are utilized by a diverse group of medical professionals, including oncologists, urologists, endocrinologists, and cytopathologists, empowering them to deliver improved patient care. The company holds a licensing agreement with Max Planck Innovation GmbH, securing rights to its patented microRNA technologies for both diagnostic applications and research initiatives. Moreover, Rosetta Genomics has entered into a collaborative partnership with Meir Medical Center to develop a microRNA classifier, focusing on non-small cell lung cancer patients being considered for immuno-oncology therapies. Established in 2000, Rosetta Genomics Ltd. maintains its headquarters in Rehovot, Israel.
Preț acțiune
$0.0001
Ultima sincronizare: 2026-08-11
Capitalizare de piață
$593.00
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
IL
Tranzacționează Rosetta Genomics Ltd. (ROSGQ)

Categorie

Healthcare
Istoric al prețului acțiunii pentru Rosetta Genomics Ltd. (ROSGQ)
Cel mai mare preț de închidere: $0.00 pe 2026-08-01

Cel mai mic preț de închidere: $64.24K pe 2007-02-01
Istoric al prețului acțiunii pentru Rosetta Genomics Ltd. din 2007 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 0.00%
2022 -97.09%
2021 -97.80%
2020 192.73%
2019 131.32%
2018 -99.68%
2017 -90.75%
2016 -57.58%
2015 -45.92%
2014 -20.59%
2013 -34.21%
2012 23.74%
2011 -94.07%
2010 -48.18%
2009 19.89%
2008 -67.95%
2007 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $603.20 26.35%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $206.22 0.24%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 $23.05 80.83%
CN
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $572.21 -12.27%
US
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $314.70 96.92%
US